Zdrowie i gospodarka · 30/10/2018
FDA Releases Draft Guidance for Dried Plasma Products
The FDA has released a draft document providing considerations for the development and licensing of dried plasma products intended for transfusion in the US, aiming to ensure the availability of safe and effective products.
Source: Federal Register — Food and Drug AdministrationOpen original release →